Legislation that will give more authority to the U.S. Food and Drug Administration (FDA) in regulating drug compounding across state lines has been agreed upon by the U.S. House of Representatives and the U.S. Senate. Along with the legislation, a set of standards will be released to fully implement the law.
The legislation would also create a national set of standards to track pharmaceuticals through the distribution chain to help thwart the introduction of fake medication into the drug supply.
The bill, named the Drug Quality and Security Act, was made after a deadly outbreak of fungal meningitis that occurred as a result of a tainted steroid from a compound in Massachusetts, and resulted in the deaths of more than 50 people. The legislation is expected to help pharmaceuticals through the distribution chain to help prevent fake medication into drug supply.